Pharmacogenomics research and its clinical implementation in Thailand: Lessons learned from the resource-limited settings

Supharat Suvichapanich, Jiraphun Jittikoon, Nuanjun Wichukchinda, Wasu Kamchaisatian, Anannit Visudtibhan, Suwat Benjapopitak, Somjai Nakornchai, Wiparat Manuyakorn, Surakameth Mahasirimongkol, Association analysis of CYP2C9*3 and phenytoin-induced severe cutaneous adverse reactions (SCARs) in Thai epilepsy children. Journal of Human Genetics. ,vol. 60, pp. 413- 417 ,(2015) , 10.1038/JHG.2015.47

Fabricio Rios-Santos, Luiz Alexandre V. Magno, Pharmacogenetics and Metabolism: Past, Present and Future InTech. ,(2012) , 10.5772/28154

Wichittra Tassaneeyakul, Somsak Tiamkao, Thawinee Jantararoungtong, Pei Chen, Shu-Yi Lin, Wei-Hsuan Chen, Parinya Konyoung, Usanee Khunarkornsiri, Narong Auvichayapat, Kasemsin Pavakul, Kongkiat Kulkantrakorn, Charoen Choonhakarn, Siranun Phonhiamhan, Namfon Piyatrakul, Thiti Aungaree, Sunsanee Pongpakdee, Praphan Yodnopaglaw, Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population Epilepsia. ,vol. 51, pp. 926- 930 ,(2010) , 10.1111/J.1528-1167.2010.02533.X

Chonlaphat Sukasem, Tim R. Cressey, Pattamawan Prapaithong, Yardpiroon Tawon, Ekawat Pasomsub, Chutatip Srichunrusami, Thawinee Jantararoungtong, Marc Lallement, Wasun Chantratita, Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV‐1 infected Thai adults British Journal of Clinical Pharmacology. ,vol. 74, pp. 1005- 1012 ,(2012) , 10.1111/J.1365-2125.2012.04288.X

Pursel M, Isaacson Barash C, Vogenberg Fr, Personalized medicine: part 1: evolution and development into theranostics. P & T : a peer-reviewed journal for formulary management. ,vol. 35, pp. 560- 576 ,(2010)

Kristin W. Weitzel, Amanda R. Elsey, Taimour Y. Langaee, Benjamin Burkley, David R. Nessl, Aniwaa Owusu Obeng, Benjamin J. Staley, Hui-Jia Dong, Robert W. Allan, J. Felix Liu, Rhonda M. Cooper-DeHoff, R. David Anderson, Michael Conlon, Michael J. Clare-Salzler, David R. Nelson, Julie A. Johnson, Clinical pharmacogenetics implementation: Approaches, successes, and challenges American Journal of Medical Genetics Part C-seminars in Medical Genetics. ,vol. 166, pp. 56- 67 ,(2014) , 10.1002/AJMG.C.31390

Vorasuk Shotelersuk, Chanin Limwongse, Surakameth Mahasirimongkol, Genetics and genomics in Thailand: challenges and opportunities. Molecular Genetics & Genomic Medicine. ,vol. 2, pp. 210- 216 ,(2014) , 10.1002/MGG3.83

Insee Sensorn, Ekaphop Sirachainan, Montri Chamnanphol, Porntip Supavilai, Darawan Pinthong, Chonlaphat Sukasem, Ekawat Pasomsub, Trachu, Association of CYP3A4/5, ABCB1 and ABCC2 polymorphisms and clinical outcomes of Thai breast cancer patients treated with tamoxifen. Pharmacogenomics and Personalized Medicine. ,vol. 6, pp. 93- 98 ,(2013) , 10.2147/PGPM.S44006

Chonlaphat Sukasem, Ramaimon Tunthong, Montri Chamnanphol, Santon, Koomdee, Puangpetch, Vathesatogkit, Promas, CYP2C19 polymorphisms in the Thai population and the clinical response to clopidogrel in patients with atherothrombotic-risk factors Pharmacogenomics and Personalized Medicine. ,vol. 6, pp. 85- 91 ,(2013) , 10.2147/PGPM.S42332

Ming Ta Michael Lee, Surakameth Mahasirimongkol, Yanfei Zhang, Wimon Suwankesawong, Usa Chaikledkaew, Cristiana Pavlidis, George P. Patrinos, Wasun Chantratita, Clinical Application of Pharmacogenomics: The Example of HLA-Based Drug-Induced Toxicity Public Health Genomics. ,vol. 17, pp. 248- 255 ,(2014) , 10.1159/000366253